P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study

Jean Yves Blay; Hans Gelderblom; P Rutkowski; AJ Wagner; M van de Sande; Silvia Stacchiotti; Axel Le Cesne; E Palmerini; Marc Vallee; B. Harrow; Christoph R. Becker; Rudresh Jarecha; Maitreyi G. Sharma; W.D. Tap

doi:10.1016/j.jval.2022.09.075

Related publications

Article2022

1509P Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion

Jean Yves Blay, H. Gelderblom, P. Rutkowski, A. Wagner, Meike van de Sande, A. Falcon Gonzalez, S. Stacchiotti, A. Le Cesne, T. Alcindor, C. Serrano, E. Palmerini, Vishnu Ravi, A. Casado Herráez, B. Seddon, Michael F. Vallee, R. Jarecha, M. Sharma, R. Ruiz-Soto, M.L. Sherman, W.D. Tap

Article2024

Efficacy, safety, and patient-reported outcomes of vimseltinib in patients with tenosynovial giant cell tumor: Results from the phase 3 MOTION trial.

William D. Tap, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Ryan Abdul Razak, Antoîne Italiano, Mahbubl Ahmed, Axel Le Cesne, Christopher Tait, Fiona Zarins, B. Harrow, Maitreyi G. Sharma, Rodrigo Ruiz‐Soto, Matthew L. Sherman, Jean Yves Blay, Hans Gelderblom

Article2024

Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Hans Gelderblom, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Abdul Razak, Antoîne Italiano, Mahbubl Ahmed, Axel Le Cesne, Gabriel Tinoco, Kjetil Boye, Javier Martín‐Broto, Emanuela Palmerini, Salvatore Tafuto, Sarah Pratap, Benjamin Powers, Peter Reichardt, Antonio Casado, Piotr Rutkowski, Christopher Tait,

Article2020

Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez‐Roca, Christophe Le Tourneau, Maud Toulmonde, Sandra P. D’Angelo, Kristy Weber, Delphine Loirat, Wolfgang Jacob, Anna-Maria Jegg, Francesca Michielin, R D Christen, Carl Watson, Michael A. Cannarile, Irina Klaman, K. Abiraj, Carola H. Ries, Maja Weisser, Dominik Rüttinger, Jean Yves Blay, Jean‐Pierre Delord

Article2025

2694P Long-term efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): 2-year results from the MOTION phase III trial

Sebastian Bauer, Vivek A. Bhadri, H. Gelderblom, S. Stacchiotti, Andrew J. Wagner, Meike van de Sande, Nicholas M. Bernthal, Albiruni Ryan Abdul Razak, A. Italiano, M. Ahmed, A. Le Cesne, Christopher Tait, Fiona Zarins, N. Zeringo, B. Harrow, Manu Sharma, M.L. Sherman, Jean Yves Blay, W.D. Tap